However, p-mTOR expression was significantly related to 1- (RR = 1.86, 95%CI: 1.50–2.31, P < 0.001, Fig 5a), 3- (RR = 1.71, 95%CI: 1.52–1.93, P < 0.001, Fig 5b), and 5-year (RR = 1.53, 95%CI: 1.26–1.86, P < 0.001, Fig 5c) OS in GC patients. Here, MTOR is linked to gastric cancer.